IBD's rasting is based on company's performance, which is still great. There is no way in advance to know that a company will loose a battle in court. The rating do not take into account such unpredictable event. I guess this is the right time to buy this IBD#1 stock. (Also those who have bought before today, would be stopped out at 8% loss as per IBD. As a side note: I am fan of IBD).
Are you kidding thinking cutr will still be IBD#1 next week? IBD does not stand by its picks. They let them run up way too high, fail, and then dump off the list altogether. I am willing to accept any odds on a bet that cutr will be gone from IBD list in a blink.